For years, the prior authorization process—a utilization management tool used by health insurance companies to determine if a medical treatment, service, or medication is medically necessary—has been the primary source of friction between the American medical community and the insurance industry. Despite high-profile pledges by insurers to streamline these bureaucratic hurdles, a new American Medical Association (AMA) survey suggests that the "reform" movement is failing to move the needle where it matters most: at the point of patient care.
Main Facts: A Reform Stalled by Skepticism
The landscape of healthcare administration is currently in a state of transition. Last year, major health insurance organizations made a series of public commitments aimed at modernizing prior authorization. These pledges focused on three core pillars: improving transparency, standardizing electronic prior authorization (ePA) protocols, and ensuring that medical necessity denials are handled with greater clinical oversight. The rollout of these initiatives is scheduled to continue through 2026 and 2027.
However, the reality on the ground, as reported by 1,000 practicing physicians in a recent AMA survey, paints a starkly different picture. The headline finding is clear: only one in three physicians (33%) believes these industry-led commitments will result in a meaningful reduction of the administrative burden that currently hampers clinical workflows.
The survey highlights a profound disconnect between the policy promises made in corporate boardrooms and the daily operational realities faced by doctors. Rather than viewing these pledges as a turning point, the physician workforce views them as another cycle of "vague or partial measures" that fail to address the fundamental issues of clinical expertise and patient-centered care.
A Chronology of Conflict: From Pledges to Present-Day Disillusionment
The history of prior authorization reform is a long, winding road of advocacy and resistance.
- 2018–2020: The AMA and other medical societies began aggressively lobbying against the excessive use of prior authorization, citing physician burnout and delayed patient care. During this period, the industry saw an increase in the use of automated algorithms to deny claims, leading to increased public scrutiny.
- 2022–2023: In response to mounting political pressure and legislative threats at both the state and federal levels, major insurance industry groups announced a "voluntary" commitment to overhaul the prior authorization process. The focus was placed on increasing transparency and adopting electronic standards to replace fax machines and phone calls.
- 2024: As implementation phases began, the AMA launched a comprehensive survey to gauge the pulse of the medical community. The data, released recently, confirmed that the voluntary nature of these reforms has done little to mitigate the deep-seated skepticism among clinicians.
- 2025–2027: The industry remains in the implementation window for these pledges. The current data serves as a mid-term report card, suggesting that without significant course correction, these years will likely be characterized by continued friction rather than systemic improvement.
Supporting Data: The Clinical Expertise Deficit
One of the most contentious aspects of prior authorization is the "peer-to-peer" review. The stated goal of these reviews is to allow a physician to discuss a patient’s unique clinical needs with a qualified health plan representative when an initial request for treatment or medication is denied.
The AMA survey results, however, suggest that these reviews are falling far short of their professional standards:
- The Expertise Gap: While insurers have committed to ensuring that medical necessity denials are reviewed by licensed, qualified clinicians, only 24% of surveyed physicians reported that these reviews are consistently conducted by clinicians with appropriate credentials for the specific medical situation.
- The Peer-to-Peer Failures: When asked about the quality of peer-to-peer reviews, only 16% of respondents indicated that the health plan representative "often or always" possesses the necessary clinical expertise to make an informed judgment on the patient’s care.
- The Burden of Time: Physicians reported that the time spent chasing authorization remains a primary contributor to professional burnout. The reliance on fragmented communication channels—despite the push for electronic standardization—continues to force medical staff to divert time away from direct patient interactions to manage insurance paperwork.
These figures represent more than just statistics; they represent a breakdown in the collaborative relationship required to manage complex chronic conditions, surgeries, and specialized medical therapies. When a generalist reviewer denies the expertise of a sub-specialist, the resulting delay in care can have tangible, sometimes life-altering consequences for the patient.
Official Responses: The AMA’s Stance
The American Medical Association has been unequivocal in its criticism of the current state of reform. Dr. Bobby Mukkamala, president of the AMA, underscored the gravity of the situation in a formal statement accompanying the survey release.
"Physician trust in voluntary insurer pledges is deeply eroded after years of unfulfilled promises," Dr. Mukkamala stated. "Physicians are especially frustrated when so-called peer-to-peer reviews are conducted by individuals who lack the appropriate clinical expertise to evaluate a patient’s care."
Dr. Mukkamala’s rhetoric reflects a shift in the AMA’s strategy. Where once there was hope for industry self-regulation, there is now an insistence on measurable, transparent, and enforceable action. He argues that the current "credibility gap" cannot be bridged by marketing campaigns or vague commitments. For the AMA, the issue is not just administrative; it is an ethical imperative to ensure that the patient’s care is not subordinated to the financial incentives of an insurer.
The Implications: What Comes Next?
The findings of this survey have significant implications for the future of healthcare policy, regulation, and the insurance-provider relationship.
1. Increased Demand for Legislative Oversight
Because voluntary pledges have failed to secure the trust of the medical community, there will likely be a surge in advocacy for federal and state-level mandates. The industry’s failure to self-regulate effectively may invite the very legislative interference it has sought to avoid for years. Lawmakers are increasingly viewing prior authorization as a patient safety issue rather than a cost-control issue.
2. The Tech-Ethics Divide
As artificial intelligence and automated systems become more integrated into the prior authorization process, the issue of "qualified review" will become even more complex. If insurers rely on algorithms to make coverage decisions, the "clinical expertise" of the human reviewer becomes a moot point unless there is total transparency regarding how those algorithms are trained and audited.
3. A Long Road to Rebuilding Trust
Rebuilding the relationship between physicians and insurers will require a radical shift in operations. According to Dr. Mukkamala, this requires "sustained, transparent, and measurable action." For insurers, this may mean:
- Third-party auditing: Allowing independent bodies to review denial patterns and the credentials of peer-to-peer reviewers.
- Standardization: Moving beyond mere "electronic capability" to actual, interoperable systems that reduce the burden on physician office staff.
- Clinical focus: Prioritizing patient outcomes over administrative denial quotas.
4. The Patient Impact
Ultimately, the patient is the one caught in the middle. When a physician spends hours fighting a denial that they believe is clinically unsound—and when that physician is convinced that the insurer’s reviewer is not qualified to make that call—the quality of care suffers. The potential for delays in essential surgeries, chemotherapy, or mental health treatment is the human cost of this ongoing administrative deadlock.
Conclusion
The latest AMA survey serves as a warning shot to the insurance industry. The "reform" period of 2026–2027 is intended to be a time of improvement, but without a fundamental change in how health plans engage with the physician community, these years may instead be defined by further polarization.
The credibility gap is wide, and the tools being used to bridge it—voluntary, partial, and opaque—are insufficient. To restore trust, the healthcare industry must move beyond the rhetoric of "pledges" and commit to a transparent, clinically-sound process that treats physicians as partners in care rather than obstacles to profit. Until then, the friction between those who pay for care and those who provide it will likely continue to stifle the health of the system at large.
